ELCRX
Price
$41.70
Change
-$0.08 (-0.19%)
Updated
Jun 2 closing price
Net Assets
462.37M
RGABX
Price
$77.29
Change
-$0.25 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

ELCRX vs RGABX

Header iconELCRX vs RGABX Comparison
Open Charts ELCRX vs RGABXBanner chart's image
ELCRX vs RGABX Comparison Chart in %
View a ticker or compare two or three
VS
ELCRX vs. RGABX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCRX is a Buy and RGABX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 338B vs. ELCRX (462M). ELCRX (0.00) and RGABX (0.00) have matching dividends . ELCRX was incepted earlier than RGABX: ELCRX (17 years) vs RGABX (24 years). RGABX (1.38) is less costly to investors than ELCRX (1.29). RGABX is a more actively managed with annual turnover of: 32.00 vs. ELCRX (20.00). RGABX has a lower initial minimum investment than ELCRX: RGABX (250) vs ELCRX (1000). RGABX annual gain was more profitable for investors over the last year : 11.79 vs. ELCRX (6.75). RGABX return over 5 years is better than : 14.79 vs. ELCRX (13.59).
ELCRXRGABXELCRX / RGABX
Total Expense Ratio1.291.3893%
Annual Report Gross Expense Ratio1.291.3893%
Fund Existence17 years24 years-
Gain YTD9.0869.72593%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.7511.7957%
Returns for 3 years37.3945.4582%
Returns for 5 years13.5914.7992%
Returns for 10 years91.3091.9899%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVR10.250.50
+5.13%
Chicago Rivet & Machine Co
WHG16.660.65
+4.06%
Westwood Holdings Group
EXPE226.37-2.00
-0.88%
Expedia Group
GPI308.32-3.19
-1.02%
Group 1 Automotive
ETON27.34-1.34
-4.67%
Eton Pharmaceuticals